These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28919716)

  • 1. Palatability and physical properties of potassium-binding resin RDX7675: comparison with sodium polystyrene sulfonate.
    Zann V; McDermott J; Jacobs JW; Davidson JP; Lin F; Korner P; Blanks RC; Rosenbaum DP
    Drug Des Devel Ther; 2017; 11():2663-2673. PubMed ID: 28919716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Pharmacodynamic Effects of the Potassium Binder RDX7675 in Mice.
    Davidson JP; King AJ; Kumaraswamy P; Caldwell JS; Korner P; Blanks RC; Jacobs JW
    J Cardiovasc Pharmacol Ther; 2018 May; 23(3):244-253. PubMed ID: 29130735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Evaluation of the Pharmacodynamics, Safety, and Tolerability of the Potassium Binder RDX7675.
    Pitt B; Zann V; Roe C; Jacobs JW; Davidson JP; Dowd C; Kumaraswamy P; Lin F; Korner P; Blanks RC; Rosenbaum DP
    J Clin Pharmacol; 2018 Aug; 58(8):1035-1043. PubMed ID: 29645278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Sodium Polystyrene Sulfonate Dosing Strategies in the Inpatient Management of Hyperkalemia.
    Mistry M; Shea A; Giguère P; Nguyen ML
    Ann Pharmacother; 2016 Jun; 50(6):455-62. PubMed ID: 27048188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease.
    Georgianos PI; Liampas I; Kyriakou A; Vaios V; Raptis V; Savvidis N; Sioulis A; Liakopoulos V; Balaskas EV; Zebekakis PE
    Int Urol Nephrol; 2017 Dec; 49(12):2217-2221. PubMed ID: 29027620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polysulfonate Resins in Hyperkalemia: A Systematic Review.
    Wong SWS; Zhang G; Norman P; Welihinda H; Wijeratne DT
    Can J Kidney Health Dis; 2020; 7():2054358120965838. PubMed ID: 33240515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compared effects of calcium and sodium polystyrene sulfonate on mineral and bone metabolism and volume overload in pre-dialysis patients with hyperkalemia.
    Nakayama Y; Ueda K; Yamagishi SI; Sugiyama M; Yoshida C; Kurokawa Y; Nakamura N; Moriyama T; Kodama G; Minezaki T; Ito S; Nagata A; Taguchi K; Yano J; Kaida Y; Shibatomi K; Fukami K
    Clin Exp Nephrol; 2018 Feb; 22(1):35-44. PubMed ID: 28421299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperkalemia treatment modalities: A descriptive observational study focused on medication and healthcare resource utilization.
    Desai NR; Rowan CG; Alvarez PJ; Fogli J; Toto RD
    PLoS One; 2020; 15(1):e0226844. PubMed ID: 31910208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD.
    Lepage L; Dufour AC; Doiron J; Handfield K; Desforges K; Bell R; Vallée M; Savoie M; Perreault S; Laurin LP; Pichette V; Lafrance JP
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2136-42. PubMed ID: 26576619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of patiromer, sodium zirconium cyclosilicate, and sodium polystyrene sulfonate for the treatment of hyperkalemia: an evidence-based review.
    Beccari MV; Meaney CJ
    Core Evid; 2017; 12():11-24. PubMed ID: 28356904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium polystyrene sulfonate for the treatment of acute hyperkalemia: a retrospective study.
    Hagan AE; Farrington CA; Wall GC; Belz MM
    Clin Nephrol; 2016 Jan; 85(1):38-43. PubMed ID: 26587776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Appropriate Sodium Polystyrene Sulfonate Use With a Hyperkalemia Order Set: A Pilot Study.
    Mueller ZT; Crannage AJ
    J Pharm Pract; 2019 Oct; 32(5):493-498. PubMed ID: 29642732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, Controlled Trial of the Effect of Dietary Potassium Restriction on Nerve Function in CKD.
    Arnold R; Pianta TJ; Pussell BA; Kirby A; O'Brien K; Sullivan K; Holyday M; Cormack C; Kiernan MC; Krishnan AV
    Clin J Am Soc Nephrol; 2017 Oct; 12(10):1569-1577. PubMed ID: 28893921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium Zirconium Cyclosilicate (ZS-9): A Novel Agent for the Treatment of Hyperkalemia.
    Linder KE; Krawczynski MA; Laskey D
    Pharmacotherapy; 2016 Aug; 36(8):923-33. PubMed ID: 27393581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of sodium polystyrene sulfonate in the inpatient management of hyperkalemia.
    Kessler C; Ng J; Valdez K; Xie H; Geiger B
    J Hosp Med; 2011 Mar; 6(3):136-40. PubMed ID: 21387549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Case report of an infant hyperkalemia: Suggestion of a hospital procedure for the milk pretreatment with sodium polystyrene sulfonate resin].
    Robert S; Nisse YE; Henn-Ménétré S; Vrillon I; Demoré B
    Ann Pharm Fr; 2020 Jul; 78(4):287-293. PubMed ID: 32439127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Study of Constipation Exacerbation by Potassium Binders Using a Loperamide-Induced Constipation Model.
    Narita Y; Fukumoto K; Fukunaga M; Kondo Y; Ishitsuka Y; Jono H; Irie T; Saito H; Kadowaki D; Hirata S
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Sodium Polystyrene Sulfonate for Short-Term Treatment of Hyperkalemia.
    Batterink J; Lin J; Au-Yeung SH; Cessford T
    Can J Hosp Pharm; 2015; 68(4):296-303. PubMed ID: 26327703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate(®)) as a treatment for hyperkalemia in infants with acute or chronic renal insufficiency.
    Thompson K; Flynn J; Okamura D; Zhou L
    J Ren Nutr; 2013 Sep; 23(5):333-9. PubMed ID: 23707305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate.
    Lee J; Moffett BS
    Pediatr Nephrol; 2016 Nov; 31(11):2113-7. PubMed ID: 27215929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.